Arnon Nagler Md

専門分野: Hematologist
46年の経験
話します:
English, Hebrew
オンラインコンサルテーション：利用可能
勤務先: イスラエル, ラマト・ガン, シェバ医療センター
イスラエル初の公的臍帯血バンクの設立者であり、同国初の臍帯血移植を実施。
アーノン・ナグラー博士は、イスラエルのシェバ医療センターの血液専門医です。テルアビブ大学の教授であり、移植の著名な専門家でもあります。ナグラー博士は、イスラエル初の公的臍帯血バンクを設立しました。また、同国初の臍帯血移植も実施しました。スタンフォード大学で博士研究員としての研修を修了し、血液学の専門医認定を受けています。
- 血液がんに対する低強度同種移植プロトコルの先駆者。
- EBMT（欧州血液骨髄移植学会）の急性白血病ワーキングパーティの議長を務めた。
- 『Blood』や『Leukemia』などの主要ジャーナルで400本以上の論文を発表。
- 2026年にNewsweek誌により世界第7位にランクされたシェバ医療センターに勤務。

Arnon Nagler Md 医師とのパッケージ取引を探る

手術を選択

CAR-T Therapy for Multiple Myeloma at Top-10 Hospitals 2026 by Newsweek Sheba Hospital

$86,000

$82,150

パッケージあたり

CAR-T Therapy for Burkitt Lymphoma at Sheba Medical Center

$86,000

パッケージあたり

CAR-T Therapy for Chronic Lymphocytic Leukemia / Richter’s Transformation at Sheba Medical Center

$85,000

パッケージあたり

CAR-T Therapy for Acute Lymphoblastic Leukemia (ALL) at Sheba Medical Center

$85,300

$81,760

パッケージあたり

CAR-T Therapy for Primary central nervous system Lymphoma at Sheba Medical Center

$86,300

パッケージあたり

CAR-T Therapy for Non-Hodgkin Lymphomas (DLBCL, FL, MCL) at Sheba Medical Center

$86,000

$81,250

パッケージあたり

Sheba Personalized CAR-T Immunotherapy Program for Blood Cancers

$85,000

パッケージあたり

Allogeneic bone marrow transplant (allo-BM) at Sheba Hospital

$165,300

パッケージあたり

Comprehensive Evaluation and Treatment Planning for Hodgkin Lymphoma at Sheba Medical Center

$9,500

パッケージあたり

パッケージにはクリニックが提供する標準的な医療サービスと宿泊、送迎などの追加特典が含まれます。

Arnon Nagler Md とのオンラインコンサルテーション

便利で簡単

100%安全で機密

お問い合わせください

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Arnon Nagler is a hematologist and a pioneer in bone marrow transplantation. He is a Professor of Medicine at Tel Aviv University. Nagler also serves as Director Emeritus at Sheba Medical Center. He founded Israel’s first public cord blood bank. He also performed the nation's first cord blood transplantations.

Specialization and Hematological Care

Arnon Nagler treats blood cancers and hematopoietic disorders — conditions that affect the production of blood cells. He pioneered reduced-intensity allogeneic transplant protocols. These protocols use lower doses of chemotherapy to make transplants safer for certain patients. Such techniques help patients with both malignant and non-malignant blood diseases. He also provides stem cell transplantation and immunotherapies.

Clinical Leadership and Achievements

Nagler has served in leadership roles across international medical organizations. He was the Chair and Co-Chair of the Scientific Council of the Acute Leukemia Working Party (ALWP) at the EBMT. He also served as a board member and treasurer for the NetCord/EuroCord global networks. Additionally, he acted as Vice-Chair of European Society for Blood and Marrow Transplantation (EBMT) committees. Nagler has received multiple awards for scientific innovation and excellence in transplant medicine.

Work Experience

Director Emeritus – Division of Hematology & Bone Marrow Transplantation and Cord Blood Bank, Sheba Medical Center, Israel
Professor of Medicine – Tel Aviv University, Israel
Vice-Chair – European Society for Blood and Marrow Transplantation (EBMT) committees and subcommittees
Principal Investigator – Major clinical trials and translational research projects
Editorial Board Member – Various international hematology and transplantation journals

Education and Training

Medical Degree – Hebrew University–Hadassah Medical School, Jerusalem, Israel
M.Sc. in Hematopoiesis – Tel Aviv University, Israel
Postdoctoral Fellowship in Hematology & Bone Marrow Transplantation – Stanford University Hospital, USA
Board Certification – Internal Medicine and Hematology

Research and Publications

Arnon Nagler is a researcher and speaker at international medical congresses. He has authored numerous studies in medical journals. His work appears in publications such as: